Complete financial analysis of Moolec Science SA (MLEC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Moolec Science SA, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- National Cement Company (Public Shareholding Co.) (NCC.AE) Income Statement Analysis – Financial Results
- Banca Mediolanum S.p.A. (BNCDY) Income Statement Analysis – Financial Results
- Yamada Holdings Co., Ltd. (9831.T) Income Statement Analysis – Financial Results
- Banco BTG Pactual S.A. (BPAC3.SA) Income Statement Analysis – Financial Results
- 8i Acquisition 2 Corp. (LAX) Income Statement Analysis – Financial Results
Moolec Science SA (MLEC)
About Moolec Science SA
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.63M | 905.05K | 0.00 | 0.00 |
| Cost of Revenue | 5.15M | 1.05M | 0.00 | 0.00 |
| Gross Profit | 472.58K | -143.31K | 0.00 | 0.00 |
| Gross Profit Ratio | 8.40% | -15.83% | 0.00% | 0.00% |
| Research & Development | 1.77M | 1.35M | 985.16K | 0.00 |
| General & Administrative | 6.54M | 47.42M | 2.52M | 0.00 |
| Selling & Marketing | 643.06K | 256.42K | 105.06K | 0.00 |
| SG&A | 7.18M | 47.67M | 2.63M | 13.80K |
| Other Expenses | 564.22K | -42.51M | 0.00 | 0.00 |
| Operating Expenses | 9.52M | 6.51M | 3.65M | 13.80K |
| Cost & Expenses | 14.67M | 7.47M | 3.65M | 13.80K |
| Interest Income | 1.39M | 693.03K | 13.32K | 0.00 |
| Interest Expense | 1.17M | 160.04K | 2.13K | 0.00 |
| Depreciation & Amortization | 1.01M | 122.02K | 1.70K | 206.30K |
| EBITDA | -6.16M | -51.74M | -3.65M | -13.80K |
| EBITDA Ratio | -109.50% | -5,716.97% | 0.00% | 0.00% |
| Operating Income | -9.04M | -6.65M | -3.65M | -13.80K |
| Operating Income Ratio | -160.76% | -735.19% | 0.00% | 0.00% |
| Total Other Income/Expenses | 683.61K | -45.37M | -872.34K | -2.00 |
| Income Before Tax | -8.36M | -52.02M | -4.53M | -13.80K |
| Income Before Tax Ratio | -148.61% | -5,748.13% | 0.00% | 0.00% |
| Income Tax Expense | -1.05M | -234.54K | 2.13K | -206.30K |
| Net Income | -7.31M | -51.79M | -4.53M | -13.80K |
| Net Income Ratio | -129.99% | -5,722.22% | 0.00% | 0.00% |
| EPS | 0.00 | -1.50 | -0.26 | 0.00 |
| EPS Diluted | 0.00 | -1.50 | -0.26 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 34.47M | 17.37M | 17.37M |
| Weighted Avg Shares Out (Dil) | 0.00 | 34.47M | 17.37M | 17.37M |
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory...
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra -...
Moolec Science Presents Fiscal Year 2024 Annual Business Update
LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of...
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the...
Moolec Received NASDAQ Bid Price Letter
LUXEMBOURG / ACCESSWIRE / September 13, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today that it received a letter (the "Nasdaq Bid Price Letter") from Nasdaq notifying the Company that, for the...
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
LUXEMBOURG / ACCESSWIRE / September 5, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024....
Top 4 Risk Off Stocks You'll Regret Missing In July
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. `
Why Is Moolec Science (MLEC) Stock Down 18% Today?
Moolec Science (NASDAQ: MLEC ) stock is falling on Monday even as the molecular farming ingredient company announced an offtake agreement with a global consumer packaged goods company. According to a press release from Moolec Science, this covers the use of...
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
LUXEMBOURG / ACCESSWIRE / July 15, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a Molecular Farming ingredient company, announced today the signing of an offtake agreement with one of the largest global consumer packaged goods and pet food companies...
Moolec Announces New Patent Granting in the United States for Molecular Farming Platform
LUXEMBOURG / ACCESSWIRE / April 30, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a Molecular Farming food-ingredient company, announced today the granting of a patent family in the United States for its SPC2 product produced in safflower with Molecular...
Source: https://incomestatements.info
Category: Stock Reports